Carried out by researchers in the United States, this clinical trial found that heart attack patients whose vitamin D levels were actively monitored and adjusted to reach an optimal blood concentration had about half the risk of a second heart attack compared with those who received no supplementation.
The study followed 630 patients who had suffered a heart attack within the previous month and monitored them for at least two years. Around 85 percent of participants started with insufficient vitamin D levels, defined as below 40 ng/mL. Patients in the treatment group received individualized vitamin D3 doses – often as high as 5,000 IU daily – aimed at pushing blood levels above this threshold, with frequent testing and dose adjustments until the target was reached. In contrast, previous trials typically prescribed standard doses without checking whether they actually corrected deficiency.
Over the follow-up period, 107 participants experienced major cardiac events such as stroke, hospitalization, or death. However, the rate of recurrent heart attacks was cut in half among those receiving targeted vitamin D management. The researchers say that larger trials are needed to see whether this approach also reduces other cardiovascular risks, but they emphasize the relevance of the findings given that vitamin D deficiency affects up to two-thirds of the global population and has long been linked to poorer heart health.
To check out Dr. Rath’s Cellular Health recommendations for healthy arteries, see this page on our website.
Minamata Convention Agrees to End the Use of Dental Amalgam by 2034
December 12, 2025A Government Cover-Up in Plain Sight: How the UK COVID-19 Inquiry Protects Power, Not People
December 12, 2025Personalized Vitamin D3 Supplementation for Heart Attacks Cuts Risk of Recurrence in Half
News
Tailored vitamin D3 supplementation for heart attack patients may halve their risk of a second heart attack, according to new clinical findings.
[Source: nutritioninsight.com]
[Image source: Freepik]
Comment
Carried out by researchers in the United States, this clinical trial found that heart attack patients whose vitamin D levels were actively monitored and adjusted to reach an optimal blood concentration had about half the risk of a second heart attack compared with those who received no supplementation.
The study followed 630 patients who had suffered a heart attack within the previous month and monitored them for at least two years. Around 85 percent of participants started with insufficient vitamin D levels, defined as below 40 ng/mL. Patients in the treatment group received individualized vitamin D3 doses – often as high as 5,000 IU daily – aimed at pushing blood levels above this threshold, with frequent testing and dose adjustments until the target was reached. In contrast, previous trials typically prescribed standard doses without checking whether they actually corrected deficiency.
Over the follow-up period, 107 participants experienced major cardiac events such as stroke, hospitalization, or death. However, the rate of recurrent heart attacks was cut in half among those receiving targeted vitamin D management. The researchers say that larger trials are needed to see whether this approach also reduces other cardiovascular risks, but they emphasize the relevance of the findings given that vitamin D deficiency affects up to two-thirds of the global population and has long been linked to poorer heart health.
To check out Dr. Rath’s Cellular Health recommendations for healthy arteries, see this page on our website.
Dr. Rath Health Foundation
Related posts
The Grand Canyon’s Water is Supposed to be Pristine. Scientists Just Found Pharmaceuticals in It
Read more